Literature DB >> 15870023

Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.

Ilan Dalal1, Uri Tabori, Bela Bielorai, Hana Golan, Eli Rosenthal, Ninette Amariglio, Gidi Rechavi, Amos Toren.   

Abstract

Mutations in both of the recombination activating genes (RAG)1 and RAG2 can lead to either T-B-severe combined immune deficiency (SCID) or Omenn syndrome (OS), two diseases presenting with totally different clinical and laboratory manifestations. The fact that the same mutations can cause either T-B- SCID or OS, even within the same family, lends credibility to the hypothesis that an additional factor (autoantigen or exoantigen) is required in certain circumstances for the development of OS phenotype. We investigated three patients from the same extended family who presented as T-B- SCID due to a homozygous mutation (G1305T) in the RAG2 gene. Our data support the notion that mutated RAG proteins may not always be sufficient to cause OS phenotype, and show evolution from a T-B- SCID into a typical OS phenotype subsequent to parainfluenza 3 virus infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870023     DOI: 10.1016/j.clim.2004.08.016

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

Review 1.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

2.  Hypomorphic Rag mutations can cause destructive midline granulomatous disease.

Authors:  Suk See De Ravin; Edward W Cowen; Kol A Zarember; Narda L Whiting-Theobald; Douglas B Kuhns; Netanya G Sandler; Daniel C Douek; Stefania Pittaluga; Pietro L Poliani; Yu Nee Lee; Luigi D Notarangelo; Lei Wang; Frederick W Alt; Elizabeth M Kang; Joshua D Milner; Julie E Niemela; Mary Fontana-Penn; Sara H Sinal; Harry L Malech
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

3.  A variant of SCID with specific immune responses and predominance of gamma delta T cells.

Authors:  Stephan Ehl; Klaus Schwarz; Anselm Enders; Ulrich Duffner; Ulrich Pannicke; Joachim Kühr; Françoise Mascart; Annette Schmitt-Graeff; Charlotte Niemeyer; Paul Fisch
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

4.  Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience.

Authors:  Srdjan Pasic; Dragana Vujic; Dobrila Veljković; Bojana Slavkovic; Marija Mostarica-Stojkovic; Predrag Minic; Aleksandra Minic; Goran Ristic; Silvia Giliani; Anna Villa; Cristina Sobacchi; Desa Lilić; Mario Abinun
Journal:  J Clin Immunol       Date:  2014-02-01       Impact factor: 8.317

5.  Selective clinical and immune response of the oligoclonal autoreactive T cells in Omenn patients after cyclosporin A treatment.

Authors:  A Lev; A J Simon; N Amariglio; G Rechavi; R Somech
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 6.  Murine models of Omenn syndrome.

Authors:  Serre-Yu Wong; David B Roth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome.

Authors:  Janet Chou; Rima Hanna-Wakim; Irit Tirosh; Jennifer Kane; David Fraulino; Yu Nee Lee; Soha Ghanem; Iman Mahfouz; André Mégarbané; Gérard Lefranc; Adlette Inati; Ghassan Dbaibo; Silvia Giliani; Luigi D Notarangelo; Raif S Geha; Michel J Massaad
Journal:  J Allergy Clin Immunol       Date:  2012-07-25       Impact factor: 10.793

Review 8.  Human RAG mutations: biochemistry and clinical implications.

Authors:  Luigi D Notarangelo; Min-Sung Kim; Jolan E Walter; Yu Nee Lee
Journal:  Nat Rev Immunol       Date:  2016-03-21       Impact factor: 53.106

9.  Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome.

Authors:  A R Gennery; M A Slatter; J Rice; L H Hoefsloot; D Barge; A McLean-Tooke; T Montgomery; J A Goodship; A D Burt; T J Flood; M Abinun; A J Cant; D Johnson
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

Review 10.  Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models.

Authors:  Joshua D Milner; Anders Fasth; Amos Etzioni
Journal:  J Clin Immunol       Date:  2008-01-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.